QuidelOrtho Corporation (LON:0A55)
London · Delayed Price · Currency is GBP · Price in USD 43.50
-0.14 (-0.31%)
At close: Jan 31, 2025
QuidelOrtho Market Cap
QuidelOrtho has a market cap or net worth of 1.47 billion as of September 16, 2025. Its market cap has decreased by -34.12% in one year.
Market Cap
1.47B
Enterprise Value
3.41B
Revenue
2.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
43.50
Market Cap Chart
Since June 3, 1991, QuidelOrtho's market cap has increased from 37.12M to 1.47B, an increase of 3,858.04%. That is a compound annual growth rate of 11.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 1.44B | -39.67% |
| Dec 31, 2024 | 2.39B | -38.10% |
| Dec 29, 2023 | 3.87B | -17.67% |
| Dec 30, 2022 | 4.70B | 13.03% |
| Dec 31, 2021 | 4.15B | -24.94% |
| Dec 31, 2020 | 5.54B | 134.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.94B |
| GSK plc | 58.89B |
| Haleon | 31.92B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.70B |
| Hikma Pharmaceuticals | 3.56B |
| HUTCHMED (China) | 2.15B |
| Genus | 1.65B |